Scalper1 News
Leadership is broad in IBD’s Medical-Products group. As of Tuesday’s close, 16 stocks had Composite Ratings of 90 or higher. Much of the leadership has come from small-cap names such as Cambrex (CBM), Vascular Solutions (VASC) and Inogen (INGN), but several large-cap names with a cardiovascular focus are acting well and trading near highs. Edwards Lifesciences (EW), with a Composite Rating of 97, is setting up in a cup-shaped base that shows a buy Scalper1 News
Scalper1 News